Statistics for Exagen (id:6969 XGN)

Valuation metrics

Market cap

72.31M

Enterprise value

47.43M

Trailing P/E (ttm)

-3.06

Forward P/E

-4.94

PEG ratio

-4.94

Price/Sales (ttm)

1.28

Price/Book (mrq)

3.08

Enterprise Value/Revenue

0.84

Enterprise Value/EBITDA

-3.44

Overview

Shares outstanding

17.64M

Float

6.78M

Shares short

52.21K

% Held by insiders

0.30%

% Held by institutions

0.57%

Average volume (10 days)

138.64K

Average volume (90 days)

Price summary

52-Week low

1.30

52-Week high

4.83

52-Week change

61.42%

Beta

1.35

50-Day moving average

2.87

200-Day moving average

2.23

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

-30.56%

Operating margin

-17.17%

Operational effectiveness

Return on assets

-17.41%

Return on equity

-69.97%

Income statement

Revenue (ttm)

3.16

Revenue per share (ttm)

3.16

Quarterly revenue growth (yoy)

Gross profit (ttm)

29.46M

EBITDA

-13,807,000.00

Net income to common (ttm)

-17,314,000.00

Diluted EPS (ttm)

-0.94

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

24.48M

Total cash per share (mrq)

1.41

Total debt (mrq)

24.10M

Total Debt/Equity (mrq)

137.03

Current ratio (mrq)

431.90%

Book value per share (mrq)

1.33

Cash flow

Cash flow statement

-6,025,000.00

Levered free cash flow (LFCF)

-2,215,750.00